Viatris (VTRS) Receivables - Other (2019 - 2026)
Viatris (VTRS) recorded quarterly Receivables - Other of $499.0 million in Q1 2026, up 9.98% quarter-over-quarter from $453.7 million in Q4 2025, and down 7.73% on a YoY basis from $540.8 million in Q1 2025.
Viatris (VTRS) Receivables - Other (2019 - 2026) Analysis & Trends
Viatris' Receivables - Other history runs 8 years deep, the most recent figure standing at $499.0 million for Q1 2026.
- In Q1 2026, Receivables - Other fell 7.73% year-over-year to $499.0 million; the TTM figure through Mar 2026 stood at $499.0 million (down 7.73% YoY), while the FY2025 annual figure was $453.7 million, down 16.9% from the prior year.
- Receivables - Other was $499.0 million for Q1 2026 at Viatris, up from $453.7 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $882.5 million in Q2 2024 to a low of $453.7 million in Q4 2025.
- Historically, Receivables - Other has averaged $591.6 million across 5 years, with a median of $537.0 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other soared 82.49% in 2024, then slumped 47.43% in 2025.
- A 5-year view of Receivables - Other shows it stood at $570.7 million in 2022, then soared by 53.6% to $876.6 million in 2023, then tumbled by 37.71% to $546.0 million in 2024, then dropped by 16.9% to $453.7 million in 2025, then rose by 9.98% to $499.0 million in 2026.
- The last three Receivables - Other figures came in at $499.0 million (Q1 2026), $453.7 million (Q4 2025), and $459.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Viatris | - | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 499.00 Mn |
| Mar 31, 2026 | 499.00 Mn |
| Dec 31, 2025 | 453.70 Mn |
| Dec 31, 2025 | 453.70 Mn |
| Sep 30, 2025 | 459.50 Mn |
| Sep 30, 2025 | 459.50 Mn |
| Jun 30, 2025 | 463.90 Mn |
| Jun 30, 2025 | 463.90 Mn |
| Mar 31, 2025 | 540.80 Mn |
| Mar 31, 2025 | 540.80 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Sep 30, 2024 | 861.00 Mn |
| Sep 30, 2024 | 861.00 Mn |
| Jun 30, 2024 | 882.50 Mn |
| Jun 30, 2024 | 882.50 Mn |
| Mar 31, 2024 | 842.00 Mn |
| Mar 31, 2024 | 842.00 Mn |
| Dec 31, 2023 | 876.60 Mn |
| Dec 31, 2023 | 876.60 Mn |